Pressey JG - Search Results

1

Targeting wild-type and mutant p53 with small molecule CP-31398 blocks the growth of rhabdomyosarcoma by inducing reactive oxygen species-dependent apoptosis.

Xu J, Timares L, Heilpern C, Weng Z, Li C, Xu H, Pressey JG, Elmets CA, Kopelovich L, Athar M. Xu J, et al. Among authors: pressey jg. Cancer Res. 2010 Aug 15;70(16):6566-76. doi: 10.1158/0008-5472.CAN-10-0942. Epub 2010 Aug 3. Cancer Res. 2010. PMID: 20682800 Free PMC article.

2

Embryonal rhabdomyosarcoma with a novel t(2;6)(p23;p21.1).

Pressey JG, Mroczek-Musulman E, Murata-Collins JL, Saito JM, Hammers Y. Pressey JG, et al. Cancer Genet Cytogenet. 2008 Nov;187(1):39-42. doi: 10.1016/j.cancergencyto.2008.07.007. Cancer Genet Cytogenet. 2008. PMID: 18992640

3

CD133 marks a myogenically primitive subpopulation in rhabdomyosarcoma cell lines that are relatively chemoresistant but sensitive to mutant HSV.

Pressey JG, Haas MC, Pressey CS, Kelly VM, Parker JN, Gillespie GY, Friedman GK. Pressey JG, et al. Among authors: pressey cs. Pediatr Blood Cancer. 2013 Jan;60(1):45-52. doi: 10.1002/pbc.24117. Epub 2012 Mar 9. Pediatr Blood Cancer. 2013. PMID: 22408058 Free PMC article.

4

Rapamycin targeting mTOR and hedgehog signaling pathways blocks human rhabdomyosarcoma growth in xenograft murine model.

Kaylani SZ, Xu J, Srivastava RK, Kopelovich L, Pressey JG, Athar M. Kaylani SZ, et al. Among authors: pressey jg. Biochem Biophys Res Commun. 2013 Jun 14;435(4):557-61. doi: 10.1016/j.bbrc.2013.05.001. Epub 2013 May 9. Biochem Biophys Res Commun. 2013. PMID: 23665330

5

GLI inhibitor GANT-61 diminishes embryonal and alveolar rhabdomyosarcoma growth by inhibiting Shh/AKT-mTOR axis.

Srivastava RK, Kaylani SZ, Edrees N, Li C, Talwelkar SS, Xu J, Palle K, Pressey JG, Athar M. Srivastava RK, et al. Among authors: pressey jg. Oncotarget. 2014 Dec 15;5(23):12151-65. doi: 10.18632/oncotarget.2569. Oncotarget. 2014. PMID: 25432075 Free PMC article.

6

Myelofibrosis in a patient with familial hemophagocytic lymphohistiocytosis.

Friedman GK, Hammers Y, Reddy V, Pressey JG. Friedman GK, et al. Among authors: pressey jg. Pediatr Blood Cancer. 2008 Jun;50(6):1260-2. doi: 10.1002/pbc.21434. Pediatr Blood Cancer. 2008. PMID: 18253962

7

Sirolimus therapy for fibromatosis and multifocal renal cell carcinoma in a child with tuberous sclerosis complex.

Pressey JG, Wright JM, Geller JI, Joseph DB, Pressey CS, Kelly DR. Pressey JG, et al. Among authors: pressey cs. Pediatr Blood Cancer. 2010 Jul 1;54(7):1035-7. doi: 10.1002/pbc.22401. Pediatr Blood Cancer. 2010. PMID: 20108343

8

2D-difference gel electrophoretic proteomic analysis of a cell culture model of alveolar rhabdomyosarcoma.

Pressey JG, Pressey CS, Robinson G, Herring R, Wilson L, Kelly DR, Kim H. Pressey JG, et al. Among authors: pressey cs. J Proteome Res. 2011 Feb 4;10(2):624-36. doi: 10.1021/pr1008493. Epub 2011 Jan 10. J Proteome Res. 2011. PMID: 21110518 Free PMC article.

9

Molecular pathogenesis of rhabdomyosarcoma.

Xia SJ, Pressey JG, Barr FG. Xia SJ, et al. Among authors: pressey jg. Cancer Biol Ther. 2002 Mar-Apr;1(2):97-104. doi: 10.4161/cbt.51. Cancer Biol Ther. 2002. PMID: 12170781 Free article. Review.

10

Physician perceptions and beliefs of phase I trials in pediatric oncology.

Gilliam MB, Madan-Swain A, Adams JM, Pressey JG. Gilliam MB, et al. Among authors: pressey jg. Pediatr Blood Cancer. 2013 Aug;60(8):E67-9. doi: 10.1002/pbc.24522. Epub 2013 Mar 19. Pediatr Blood Cancer. 2013. PMID: 23512880 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

69 results

Search Page

Filters